Forward P/E ratio
Search documents
Why Intuitive Surgical, Inc. (ISRG) Dipped More Than Broader Market Today
ZACKS· 2025-07-11 22:51
Company Performance - Intuitive Surgical, Inc. (ISRG) stock was down 2.66% at $512.06, underperforming the S&P 500's daily loss of 0.33% [1] - Over the previous month, ISRG shares gained 2.54%, outperforming the Medical sector's loss of 0.32% but underperforming the S&P 500's gain of 4.07% [1] Upcoming Earnings - The upcoming earnings report for Intuitive Surgical is expected on July 22, 2025, with a forecasted EPS of $1.92, reflecting a 7.87% increase from the same quarter last year [2] - Revenue is projected at $2.35 billion, indicating a 16.81% rise from the equivalent quarter last year [2] Full Year Estimates - For the full year, earnings are projected at $7.84 per share and revenue at $9.65 billion, showing increases of +6.81% and +15.56% respectively from the previous year [3] Analyst Estimates - Recent changes to analyst estimates for Intuitive Surgical reflect short-term business trends, with positive revisions indicating optimism about the business outlook [3] Zacks Rank - Intuitive Surgical is currently rated as Zacks Rank 2 (Buy), with the Zacks Rank system showing a strong track record of performance [5] Valuation Metrics - The company has a Forward P/E ratio of 67.09, significantly higher than the industry average of 23.76 [6] - The PEG ratio for ISRG is 4.44, compared to the Medical - Instruments industry's average PEG ratio of 2.29 [6] Industry Overview - The Medical - Instruments industry, part of the Medical sector, has a Zacks Industry Rank of 168, placing it in the bottom 32% of over 250 industries [7] - Top-rated industries (top 50%) outperform the bottom half by a factor of 2 to 1 [7]
BRF (BRFS) Declines More Than Market: Some Information for Investors
ZACKS· 2025-07-11 22:51
Company Performance - BRF's stock price decreased by 3.23% to $3.90, underperforming the S&P 500's daily loss of 0.33% [1] - Over the past month, BRF shares increased by 9.81%, outperforming the Consumer Staples sector's decline of 0.8% and the S&P 500's gain of 4.07% [1] Financial Projections - BRF is expected to report earnings of $0.11 per share, indicating no growth compared to the same quarter last year [2] - For the entire fiscal year, earnings are projected at $0.39 per share and revenue at $12.15 billion, reflecting increases of +8.33% and +11.05% respectively from the previous year [2] Analyst Sentiment - Recent revisions to analyst forecasts for BRF are important as they indicate changing near-term business trends and analysts' confidence in performance [3] Valuation Metrics - BRF has a Forward P/E ratio of 10.33, which is lower than the industry average of 16.17, suggesting it is trading at a discount [6] - The company has a PEG ratio of 0.25, significantly below the industry average PEG ratio of 1.63 [6] Industry Context - The Food - Miscellaneous industry, which includes BRF, has a Zacks Industry Rank of 185, placing it in the bottom 26% of over 250 industries [7] - Stronger industry groups, as indicated by the Zacks Industry Rank, tend to outperform weaker groups by a factor of 2 to 1 [7]
Baidu Inc. (BIDU) Falls More Steeply Than Broader Market: What Investors Need to Know
ZACKS· 2025-07-11 22:46
Company Overview - Baidu Inc. closed at $86.95, down 1.68% from the previous trading session, underperforming the S&P 500, which lost 0.33% [1] - The stock has increased by 0.72% over the past month, lagging behind the Computer and Technology sector's gain of 5.24% and the S&P 500's gain of 4.07% [1] Upcoming Earnings - The upcoming earnings per share (EPS) for Baidu Inc. is projected at $2.05, indicating a 29.07% decline compared to the same quarter last year [2] - Revenue is expected to be $4.61 billion, reflecting a 1.37% decrease from the year-ago quarter [2] Full-Year Estimates - Zacks Consensus Estimates forecast earnings of $9.28 per share and revenue of $18.73 billion for the full year, representing year-over-year changes of -11.87% and +1.28%, respectively [3] - Recent changes to analyst estimates suggest evolving short-term business trends, with positive revisions indicating analysts' confidence in business performance [3] Valuation Metrics - Baidu Inc. is currently trading with a Forward P/E ratio of 9.53, which is a discount compared to the industry average Forward P/E of 20.25 [6] - The Internet - Services industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 149, placing it in the bottom 40% of over 250 industries [6] Zacks Rank System - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has a history of outperforming, with 1 stocks returning an average annual gain of +25% since 1988 [5] - Baidu Inc. currently holds a Zacks Rank of 4 (Sell), with no changes in the Zacks Consensus EPS estimate over the past month [5]
Uber Technologies (UBER) Falls More Steeply Than Broader Market: What Investors Need to Know
ZACKS· 2025-07-11 22:46
In the latest close session, Uber Technologies (UBER) was down 1.05% at $95.39. This change lagged the S&P 500's 0.33% loss on the day. At the same time, the Dow lost 0.63%, and the tech-heavy Nasdaq lost 0.22%. Shares of the ride-hailing company witnessed a gain of 12.59% over the previous month, beating the performance of the Computer and Technology sector with its gain of 5.24%, and the S&P 500's gain of 4.07%.Market participants will be closely following the financial results of Uber Technologies in its ...
Nu Holdings Ltd. (NU) Sees a More Significant Dip Than Broader Market: Some Facts to Know
ZACKS· 2025-07-11 22:46
Company Performance - Nu Holdings Ltd. ended the recent trading session at $12.83, showing a -1.53% change from the previous day's closing price, underperforming the S&P 500 which lost 0.33% [1] - The company's shares have increased by 8.58% over the last month, outperforming the Finance sector's gain of 3.2% and the S&P 500's gain of 4.07% [1] Upcoming Earnings - Nu Holdings Ltd. is set to disclose its earnings on August 14, 2025, with projected earnings of $0.12 per share, indicating no growth from the prior-year quarter [2] - The consensus estimate for revenue is $3.66 billion, reflecting a 28.32% increase compared to the year-ago quarter [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $0.54 per share and revenue at $14.9 billion, representing changes of +20% and +29.38% respectively from the prior year [3] - Recent changes to analyst estimates indicate optimism regarding the business and profitability [3] Valuation Metrics - Nu Holdings Ltd. has a Forward P/E ratio of 23.98, which is a premium compared to the industry average Forward P/E of 10.06 [6] - The company holds a PEG ratio of 0.74, while the average PEG ratio for the Banks - Foreign industry is 0.99 [6] Industry Context - The Banks - Foreign industry is part of the Finance sector and currently holds a Zacks Industry Rank of 26, placing it in the top 11% of over 250 industries [7] - The Zacks Industry Rank evaluates the strength of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]
BlackRock (BLK) Beats Stock Market Upswing: What Investors Need to Know
ZACKS· 2025-07-10 23:16
Company Performance - BlackRock (BLK) closed at $1,104.05, marking a +1.41% move from the prior day, outperforming the S&P 500's daily gain of 0.28% [1] - The stock has risen by 9.61% in the past month, leading the Finance sector's gain of 2.79% and the S&P 500's gain of 4.37% [1] Earnings Estimates - BlackRock is set to release its earnings on July 15, 2025, with projected EPS of $10.77, indicating a 3.96% increase year-over-year [2] - Revenue is expected to be $5.38 billion, up 12.02% from the prior-year quarter [2] - For the full year, analysts expect earnings of $45.73 per share and revenue of $22.72 billion, reflecting changes of +4.86% and +11.33% respectively from last year [3] Analyst Sentiment - Recent modifications to analyst estimates for BlackRock indicate changing near-term business trends, with positive revisions reflecting analyst optimism [4] - The Zacks Rank system, which assesses these estimate changes, currently ranks BlackRock at 2 (Buy) [6] Valuation Metrics - BlackRock has a Forward P/E ratio of 23.81, compared to the industry average of 12.15, suggesting it is trading at a premium [7] - The company has a PEG ratio of 3.25, while the average PEG ratio for the Financial - Investment Management industry is 1.42 [8] Industry Context - The Financial - Investment Management industry is part of the Finance sector and holds a Zacks Industry Rank of 62, placing it in the top 26% of all industries [9]
Why Target (TGT) Outpaced the Stock Market Today
ZACKS· 2025-07-10 22:46
Company Performance - Target's stock closed at $104.74, reflecting a +2.26% change from the previous day's closing price, outperforming the S&P 500's daily gain of 0.28% [1] - The stock has increased by 4.4% over the past month, leading the Retail-Wholesale sector's gain of 0.87% and the S&P 500's gain of 4.37% [1] Earnings Forecast - Target is expected to report an EPS of $2.08, indicating a 19.07% decrease from the same quarter last year, with a projected quarterly revenue of $24.88 billion, down 2.26% year-over-year [2] - Full-year estimates predict earnings of $7.55 per share and revenue of $104.65 billion, representing year-over-year declines of -14.79% and -1.79%, respectively [3] Analyst Estimates and Rankings - Recent changes in analyst estimates are crucial for investors, as they reflect the evolving business landscape, with positive revisions indicating confidence in performance [3][4] - Target currently holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate having increased by 0.57% over the last 30 days [5] Valuation Metrics - Target's Forward P/E ratio stands at 13.57, which is a discount compared to the industry average of 20.89 [6] - The PEG ratio for Target is 2.93, compared to the Retail - Discount Stores industry's average PEG ratio of 2.76 [6] Industry Context - The Retail - Discount Stores industry is part of the Retail-Wholesale sector and has a Zacks Industry Rank of 90, placing it in the top 37% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]
Intel (INTC) Surpasses Market Returns: Some Facts Worth Knowing
ZACKS· 2025-07-10 22:46
Company Performance - Intel's stock closed at $23.82, with a daily increase of +1.62%, outperforming the S&P 500's gain of 0.28% [1] - Over the past month, Intel's stock has risen by 13.35%, surpassing the Computer and Technology sector's gain of 6.2% and the S&P 500's gain of 4.37% [1] Upcoming Earnings - Intel's earnings report is expected on July 24, 2025, with a forecasted EPS of $0.01, reflecting a 50% decrease from the same quarter last year [2] - Revenue is projected to be $11.87 billion, indicating a 7.53% decline compared to the year-ago quarter [2] Full Year Projections - For the full year, earnings are estimated at $0.28 per share, representing a +315.38% change from the prior year, while revenue is projected at $50.8 billion, showing a -4.33% change [3] Analyst Estimates - Recent modifications to analyst estimates for Intel indicate near-term business trends, with upward revisions suggesting analysts' positivity towards the company's operations [4] - The Zacks Rank system, which reflects these estimate changes, currently rates Intel at 4 (Sell), with a recent downward shift of 3.8% in the EPS estimate [6] Valuation Metrics - Intel's Forward P/E ratio stands at 84.09, significantly higher than the industry average of 39 [7] - The company has a PEG ratio of 8.02, compared to the Semiconductor - General industry's average PEG ratio of 2.72 [7] Industry Context - The Semiconductor - General industry is part of the Computer and Technology sector, holding a Zacks Industry Rank of 62, placing it in the top 26% of over 250 industries [8]
Howmet (HWM) Surpasses Market Returns: Some Facts Worth Knowing
ZACKS· 2025-07-09 23:16
Company Performance - Howmet (HWM) stock increased by 1.09% to $181.42, outperforming the S&P 500's daily gain of 0.61% [1] - Over the past month, Howmet's stock has risen by 6.43%, leading the Aerospace sector's gain of 1.1% and the S&P 500's gain of 3.85% [1] Upcoming Earnings - Howmet is expected to report an EPS of $0.87, reflecting a 29.85% increase from the same quarter last year [2] - Revenue is forecasted to be $1.99 billion, indicating a 5.78% growth compared to the same quarter last year [2] Full Year Estimates - Analysts project earnings of $3.47 per share and revenue of $8.06 billion for the full year, representing increases of 29% and 8.53% respectively from last year [3] - Recent changes to analyst estimates suggest positive sentiment regarding Howmet's business and profitability [3] Analyst Ratings and Valuation - Howmet currently holds a Zacks Rank of 1 (Strong Buy), with a history of outperforming the market [5] - The Forward P/E ratio for Howmet is 51.77, which is a premium compared to the industry average of 24.54 [5] - The PEG ratio for Howmet stands at 2.72, compared to the Aerospace - Defense industry average of 2.05 [6] Industry Context - The Aerospace - Defense industry is ranked 60 in the Zacks Industry Rank, placing it in the top 25% of over 250 industries [6] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]
Adma Biologics (ADMA) Outperforms Broader Market: What You Need to Know
ZACKS· 2025-07-09 22:51
Group 1 - Adma Biologics' stock closed at $18.34, reflecting a +2.98% change from the previous day's closing price, outperforming the S&P 500's daily gain of 0.61% [1] - The company has experienced a 14.62% decline in stock price over the past month, while the Medical sector saw a slight loss of 0.67% [1] Group 2 - The upcoming financial results for Adma Biologics are anticipated to show an EPS of $0.14, representing a 7.69% increase from the same quarter last year, with revenue expected to reach $121.1 million, a 12.98% rise year-over-year [2] - For the full year, analysts project earnings of $0.61 per share and revenue of $505.8 million, indicating increases of +24.49% and +18.61% respectively compared to the previous year [3] Group 3 - Recent changes to analyst estimates for Adma Biologics are seen as reflective of short-term business dynamics, with positive revisions indicating a favorable business outlook [3] - The Zacks Rank system, which evaluates estimate changes, currently ranks Adma Biologics at 4 (Sell), with the consensus EPS estimate having decreased by 8.27% in the past month [5] Group 4 - Adma Biologics is trading at a Forward P/E ratio of 29.2, which is a premium compared to the industry average Forward P/E of 19.46 [6] - The Medical - Biomedical and Genetics industry, to which Adma Biologics belongs, holds a Zacks Industry Rank of 75, placing it in the top 31% of over 250 industries [6]